comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists of semaglutide for patients type 2 diabetes in clinical practice Cardiovascular Effects and Tolerability of
Description
North America dominates the market landscape, supported by favorable reimbursement policies, advanced healthcare infrastructure, and high treatment adoption rates
The starting dose is deliberately conservative to allow for this dual adaptation
Side Effects to Know About The most common side effects are digestive: Nausea & Vomiting Diarrhea or constipation Bloating These often improve after the first few weeks as your body adjusts
doi: 10.1038/s41591-022-01707-4 78 US National Institutes of Health
